18.39USD-0.81%Mkt Cap: 518.31M USDP/E: —Last update: 2026-06-01
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap518.31M USD
Enterprise Value243.40M USD
Revenue (TTM)320.35M USD
Gross Profit130.88M USD
Net Income (TTM)-60.51M USD
Revenue/Share10.40 USD
Last Price18.39 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.3K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS3596641098
Valuation
P/E (Trailing)—
P/E (Forward)-11.87
PEG—
EV/EBITDA-3.15
EV/Revenue0.76
P/S1.61
P/B0.50
EPS (TTM)-2.40
EPS (Forward)-1.53
52W Range
13.4628% of range31.04
52W High31.04 USD
52W Low13.46 USD
Profitability
Gross Margin40.56%
Oper. Margin-45.01%
EBITDA Margin-24.10%
Profit Margin-18.75%
ROE-5.44%
ROA-4.99%
Growth
Revenue Growth-3.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-101.64M USD
CapEx (TTM)22.57M USD
FCF Margin-33.07%
FCF Yield-20.44%
Net Debt-266.13M USD
Net Debt/EBITDA3.45
Balance Sheet
Debt/Equity0.01
Current Ratio5.32
Quick Ratio3.91
Book Value/Sh36.39 USD
Cash/Share9.729 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)18.50 USD
Target Range15.00 USD – 22.00 USD
# Analysts2
Ownership
Shares Out.28.40M
Float17.58M
Insiders36.71%
Institutions63.61%
Short Interest
Short Ratio5.0d
Short % Float15.09%
Short % Out.9.58%
Shares Short2.72M
Short (prev mo.)2.66M
Technical
SMA 5015.95 (+15.3%)
SMA 20021.95 (-16.2%)
Beta0.88
S&P 52W Chg27.94%
Avg Vol (30d)502.32K
Avg Vol (10d)482.28K
Technical Indicators
RSI (14)70.3
MACD0.5912
MACD Signal0.2760
MACD Hist.+0.3152
BB Upper18.63 USD
BB Middle16.23 USD
BB Lower13.82 USD
BB Width29.62%
ATR (14)0.6917 USD
Vol Ratio (20d)0.32x